Enliven Therapeutics, Inc. ELVN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-03-12
Enliven Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| CITADEL ADVISORS LLC | 1,871,515 | $73.4M |
| BlackRock Finance, Inc. | 2,730,773 | $63.8M |
| MILLENNIUM MANAGEMENT LLC | 345,318 | $13.5M |
| D. E. Shaw & Co., Inc. | 193,531 | $7.6M |
| Point72 Asset Management, L.P. | 39,600 | $1.6M |
Source: SEC EDGAR filings · CIK 0001672619 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.